Helus Pharma Inc.

HELP·NASDAQ·$4.43Share Price as of 11/2·$221MMarket Cap as of 11/2

Financials

40-FAnnual report (Canadian)06/29/26 40-FAnnual report (Canadian)07/01/25 40-FAnnual report (Canadian)06/26/24 40-FAnnual report (Canadian)06/27/23 40-F/AAnnual report (Canadian, amended)07/22/22

Disclosures

6-KForeign issuer report10/27/26 6-KForeign issuer report10/21/26 6-KForeign issuer report10/15/26 6-KForeign issuer report10/08/26 6-KForeign issuer report10/05/26

Prospectuses and Registrations

S-8Registration of securities for employees09/01/26 FWPFree writing prospectus06/24/26 F-10Prospectus / registration12/19/25 F-XProspectus / registration12/19/25 FWPFree writing prospectus10/28/25

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership10/26/26 Form 3Initial insider ownership10/26/26 Form 3Initial insider ownership10/23/26 Form 3Initial insider ownership10/23/26 Form 3Initial insider ownership10/23/26

Other

DD09/01/26 DD08/19/26 DD08/19/26 DD07/16/26 DD07/16/26